Logo image of 1GILD.MI

GILEAD SCIENCES INC (1GILD.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:1GILD - US3755581036 - Common Stock

105.88 EUR
+7.72 (+7.86%)
Last: 10/20/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to 1GILD. 1GILD was compared to 81 industry peers in the Biotechnology industry. While 1GILD has a great profitability rating, there are some minor concerns on its financial health. 1GILD may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make 1GILD a good candidate for value investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year 1GILD was profitable.
1GILD had a positive operating cash flow in the past year.
Each year in the past 5 years 1GILD has been profitable.
In the past 5 years 1GILD always reported a positive cash flow from operatings.
1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCF1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

Looking at the Return On Assets, with a value of 13.86%, 1GILD belongs to the top of the industry, outperforming 85.14% of the companies in the same industry.
1GILD has a Return On Equity of 37.80%. This is amongst the best in the industry. 1GILD outperforms 95.95% of its industry peers.
1GILD has a Return On Invested Capital of 18.54%. This is amongst the best in the industry. 1GILD outperforms 91.89% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1GILD is above the industry average of 13.22%.
The last Return On Invested Capital (18.54%) for 1GILD is above the 3 year average (16.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROIC 18.54%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
1GILD.MI Yearly ROA, ROE, ROIC1GILD.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

1GILD has a better Profit Margin (27.88%) than 87.84% of its industry peers.
1GILD's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 38.96%, 1GILD belongs to the best of the industry, outperforming 93.24% of the companies in the same industry.
In the last couple of years the Operating Margin of 1GILD has grown nicely.
The Gross Margin of 1GILD (78.72%) is better than 68.92% of its industry peers.
1GILD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
1GILD.MI Yearly Profit, Operating, Gross Margins1GILD.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1GILD is creating value.
Compared to 1 year ago, 1GILD has about the same amount of shares outstanding.
Compared to 5 years ago, 1GILD has less shares outstanding
Compared to 1 year ago, 1GILD has a worse debt to assets ratio.
1GILD.MI Yearly Shares Outstanding1GILD.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
1GILD.MI Yearly Total Debt VS Total Assets1GILD.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

1GILD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC2.31
WACC8.01%
1GILD.MI Yearly LT Debt VS Equity VS FCF1GILD.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

1GILD has a Current Ratio of 1.53. This is a normal value and indicates that 1GILD is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 1GILD (1.53) is comparable to the rest of the industry.
A Quick Ratio of 1.17 indicates that 1GILD should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.17, 1GILD is not doing good in the industry: 66.22% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.17
1GILD.MI Yearly Current Assets VS Current Liabilites1GILD.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

5

3. Growth

3.1 Past

1GILD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.88%, which is quite impressive.
The Earnings Per Share has been decreasing by -7.01% on average over the past years.
The Revenue has been growing slightly by 2.78% in the past year.
1GILD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.08% yearly.
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%

3.2 Future

The Earnings Per Share is expected to grow by 19.75% on average over the next years. This is quite good.
Based on estimates for the next years, 1GILD will show a small growth in Revenue. The Revenue will grow by 4.34% on average per year.
EPS Next Y77.74%
EPS Next 2Y37.95%
EPS Next 3Y27.38%
EPS Next 5Y19.75%
Revenue Next Year1.79%
Revenue Next 2Y2.77%
Revenue Next 3Y3.74%
Revenue Next 5Y4.34%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
1GILD.MI Yearly Revenue VS Estimates1GILD.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
1GILD.MI Yearly EPS VS Estimates1GILD.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.93, which indicates a correct valuation of 1GILD.
86.49% of the companies in the same industry are more expensive than 1GILD, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.31, 1GILD is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 13.95, the valuation of 1GILD can be described as correct.
1GILD's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1GILD is cheaper than 89.19% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.56. 1GILD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 14.93
Fwd PE 13.95
1GILD.MI Price Earnings VS Forward Price Earnings1GILD.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1GILD is valued cheaper than 86.49% of the companies in the same industry.
87.84% of the companies in the same industry are more expensive than 1GILD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.94
EV/EBITDA 10.1
1GILD.MI Per share data1GILD.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1GILD has an outstanding profitability rating, which may justify a higher PE ratio.
1GILD's earnings are expected to grow with 27.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y37.95%
EPS Next 3Y27.38%

6

5. Dividend

5.1 Amount

1GILD has a Yearly Dividend Yield of 2.67%. Purely for dividend investing, there may be better candidates out there.
1GILD's Dividend Yield is rather good when compared to the industry average which is at 10.20. 1GILD pays more dividend than 93.24% of the companies in the same industry.
1GILD's Dividend Yield is comparable with the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 2.67%

5.2 History

The dividend of 1GILD has a limited annual growth rate of 4.45%.
Dividend Growth(5Y)4.45%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

12.00% of the earnings are spent on dividend by 1GILD. This is a low number and sustainable payout ratio.
The dividend of 1GILD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP12%
EPS Next 2Y37.95%
EPS Next 3Y27.38%
1GILD.MI Yearly Income VS Free CF VS Dividend1GILD.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
1GILD.MI Dividend Payout.1GILD.MI Dividend Payout, showing the Payout Ratio.1GILD.MI Dividend Payout.PayoutRetained Earnings

GILEAD SCIENCES INC

BIT:1GILD (10/20/2025, 7:00:00 PM)

105.88

+7.72 (+7.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-09 2026-02-09/amc
Inst Owners90.76%
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap131.38B
Revenue(TTM)29.09B
Net Income(TTM)8.11B
Analysts81.11
Price Target112.24 (6.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.67%
Yearly Dividend2.72
Dividend Growth(5Y)4.45%
DP12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)2.79%
PT rev (3m)7.28%
EPS NQ rev (1m)-2.63%
EPS NQ rev (3m)2.11%
EPS NY rev (1m)-0.8%
EPS NY rev (3m)0.9%
Revenue NQ rev (1m)0.56%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE 14.93
Fwd PE 13.95
P/S 5.22
P/FCF 15.94
P/OCF 15.7
P/B 7.07
P/tB N/A
EV/EBITDA 10.1
EPS(TTM)7.09
EY6.7%
EPS(NY)7.59
Fwd EY7.17%
FCF(TTM)6.64
FCFY6.27%
OCF(TTM)6.74
OCFY6.37%
SpS20.29
BVpS14.97
TBVpS-3.37
PEG (NY)0.19
PEG (5Y)N/A
Graham Number48.86
Profitability
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROCE 24.51%
ROIC 18.54%
ROICexc 23.24%
ROICexgc 80.87%
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
FCFM 32.73%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 68.56%
Profit Quality 117.39%
Current Ratio 1.53
Quick Ratio 1.17
Altman-Z N/A
F-Score7
WACC8.01%
ROIC/WACC2.31
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
EPS Next Y77.74%
EPS Next 2Y37.95%
EPS Next 3Y27.38%
EPS Next 5Y19.75%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%
Revenue Next Year1.79%
Revenue Next 2Y2.77%
Revenue Next 3Y3.74%
Revenue Next 5Y4.34%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year75.69%
EBIT Next 3Y25.29%
EBIT Next 5Y19.07%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%

GILEAD SCIENCES INC / 1GILD.MI FAQ

What is the ChartMill fundamental rating of GILEAD SCIENCES INC (1GILD.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1GILD.MI.


What is the valuation status of GILEAD SCIENCES INC (1GILD.MI) stock?

ChartMill assigns a valuation rating of 8 / 10 to GILEAD SCIENCES INC (1GILD.MI). This can be considered as Undervalued.


What is the profitability of 1GILD stock?

GILEAD SCIENCES INC (1GILD.MI) has a profitability rating of 8 / 10.


Can you provide the financial health for 1GILD stock?

The financial health rating of GILEAD SCIENCES INC (1GILD.MI) is 5 / 10.


How sustainable is the dividend of GILEAD SCIENCES INC (1GILD.MI) stock?

The dividend rating of GILEAD SCIENCES INC (1GILD.MI) is 5 / 10 and the dividend payout ratio is 12%.